Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Scott Haughie"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
A recent study by Zimmerman et al. (2023) reported non-significant higher relative vaccine effectiveness of recombinant (RIV4) over the standard-dose influenza vaccines (SDIV) against outpatient illness during the 2018–19 and 2019–20 vaccination
Externí odkaz:
https://doaj.org/article/6dd54ec73254419e8db055e43573041e
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
A recent study reported that the high-dose quadrivalent influenza vaccine provided superior immunogenicity and efficacy versus the standard-dose quadrivalent vaccine in the elderly. However, we need to view these results in terms of public health ben
Externí odkaz:
https://doaj.org/article/7fb7947901144b1284662f2cbd7108d2
Autor:
Richard Allan, Dik Ng, Scott Haughie, Martha V White, Jonathan Ward, S. David Miller, Edward Kerwin
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Background: Wixela® Inhub® is a dry powder inhaler approved as a generic equivalent to Advair® Diskus® (fluticasone propionate [FP]/salmeterol fixed-dose combination) for patients with asthma or chronic obstructive pulmonary disease (COPD). This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d662a738dc9903db09fa23593d0f2edb
https://doi.org/10.1089/jamp.2019.1547
https://doi.org/10.1089/jamp.2019.1547
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Background: Wixela® Inhub® was developed to deliver inhaled fluticasone propionate/salmeterol (FP/S) combination as a substitutable generic equivalent to Advair® Diskus®. These studies aimed to confirm the pharmacokinetic bioequivalence (BE) of F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db4b28c6e9e83b36c27b64ff89adccf8
http://europepmc.org/articles/PMC7041328
http://europepmc.org/articles/PMC7041328
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32:352-363
Background: Asthma is widely treated using inhaled corticosteroid/long-acting beta agonist (LABA) combinations, for example, fluticasone propionate/salmeterol (FPS) dry powder inhaler, marketed as Advair® Diskus®. Some regulators require generics t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2d11c5c976cc18470c3f37c3120988b
https://doi.org/10.1089/jamp.2018.1519
https://doi.org/10.1089/jamp.2018.1519
Autor:
Elise Burmeister Getz, Scott Haughie, Hayden Beresford, Svetlana Lyapustina, Christopher Wiggenhorn, Alessandro Cavecchi, J. David Christopher, Helen Strickland, Kevin J. Carroll, Beth Morgan
Publikováno v:
AAPS PharmSciTech
Batch-to-batch pharmacokinetic (PK) variability of orally inhaled drug products has been documented and can render single-batch PK bioequivalence (BE) studies unreliable; results from one batch may not be consistent with a repeated study using a diff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c2f34313abb34c36d09442a1e758ba0
https://doi.org/10.1208/s12249-021-02063-1
https://doi.org/10.1208/s12249-021-02063-1
Publikováno v:
Biodrugs
Since the approval and availability of the first biosimilar in 2015 in the United States (US), evidence regarding the post-marketing safety of cancer supportive care biosimilars remains limited.The aim was to explore the adverse event (AE) reporting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4f4590bd55204aa68312cd76916481b
https://pubmed.ncbi.nlm.nih.gov/33860920
https://pubmed.ncbi.nlm.nih.gov/33860920
Publikováno v:
Journal of aerosol medicine and pulmonary drug delivery. 32(6)
Background: Asthma is widely treated using inhaled corticosteroid/long-acting beta-agonist combinations, such as fluticasone propionate/salmeterol (FPS) dry powder inhaler. Some regulators...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acdea6e63dfef0c38477986c9d609622
https://pubmed.ncbi.nlm.nih.gov/31259655
https://pubmed.ncbi.nlm.nih.gov/31259655
Autor:
David L. Hava, Perry Jason M, Scott Haughie, Lisa Tan, Michael Silverman, Jonathan Ward, Katie Kane, Sacha Arsova, Brian Trautman, Joe Takher‐Smith, Wolfram Richter, Valentin Kirkov, Steve Kramer
Publikováno v:
British journal of clinical pharmacology. 85(3)
AIMS: Plasma pharmacokinetics permit the assessment of efficacy and safety of inhaled drugs, and possibly their bioequivalence to other inhaled products. Correlating drug product attributes to lung deposited dose is important to achieving equivalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fae8dd36e9a3990a3fa6f9e7cc6ae437
https://pubmed.ncbi.nlm.nih.gov/30521129
https://pubmed.ncbi.nlm.nih.gov/30521129
Autor:
Steff Lewis, Nigel Baker, Judith Anzures-Cabrera, Anne Whitehead, Patrick Moneuse, Scott Haughie, Sally Hollis, Betsy Anagnostelis, Julian P T Higgins, Peter W. Lane, Joseph C. Cappelleri
Publikováno v:
Research Synthesis Methods. 4:351-366
Background: Because meta-analyses are increasingly prevalent and cited in the medical literature, it is important that tools are available to assess their methodological quality. When performing an empirical study of the quality of published meta-ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6359d929cd697cc5343f2f5085369929
https://doi.org/10.1002/jrsm.1092
https://doi.org/10.1002/jrsm.1092